FERRARI, FEDERICA
 Distribuzione geografica
Continente #
EU - Europa 1.011
NA - Nord America 971
AS - Asia 936
SA - Sud America 93
AF - Africa 34
Totale 3.045
Nazione #
US - Stati Uniti d'America 946
RU - Federazione Russa 850
SG - Singapore 391
CN - Cina 260
VN - Vietnam 140
FR - Francia 51
BR - Brasile 47
IT - Italia 33
HK - Hong Kong 31
DE - Germania 25
IN - India 24
AR - Argentina 22
GB - Regno Unito 21
BD - Bangladesh 16
IQ - Iraq 12
MX - Messico 11
CA - Canada 10
ZA - Sudafrica 9
CL - Cile 8
DZ - Algeria 8
NL - Olanda 8
CO - Colombia 7
ID - Indonesia 7
ES - Italia 5
JO - Giordania 5
PH - Filippine 5
PL - Polonia 5
TR - Turchia 5
JP - Giappone 4
KE - Kenya 4
PK - Pakistan 4
KR - Corea 3
MA - Marocco 3
MY - Malesia 3
OM - Oman 3
PE - Perù 3
UA - Ucraina 3
UY - Uruguay 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BJ - Benin 2
CI - Costa d'Avorio 2
EG - Egitto 2
IL - Israele 2
JM - Giamaica 2
LB - Libano 2
SA - Arabia Saudita 2
TH - Thailandia 2
VE - Venezuela 2
AM - Armenia 1
AO - Angola 1
AT - Austria 1
AW - Aruba 1
BG - Bulgaria 1
CG - Congo 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ET - Etiopia 1
GE - Georgia 1
IE - Irlanda 1
IR - Iran 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
MK - Macedonia 1
NP - Nepal 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
YE - Yemen 1
Totale 3.045
Città #
St Louis 343
Singapore 218
San Jose 197
Council Bluffs 106
Ashburn 85
Lauterbourg 48
Chicago 45
Ho Chi Minh City 40
New York 36
Hanoi 34
Moscow 31
Hong Kong 30
Falkenstein 13
Los Angeles 13
Orem 12
Guangzhou 11
Beijing 9
Dallas 9
Santa Clara 9
Denver 8
Da Nang 7
Chennai 6
Florence 6
Shanghai 6
São Paulo 6
Amman 5
Amsterdam 5
Baghdad 5
Brooklyn 5
Cape Town 5
Erbil 5
Hangzhou 5
Milan 5
Montreal 5
Poplar 5
Atlanta 4
Buenos Aires 4
Dalian 4
Frankfurt am Main 4
Haiphong 4
Qingdao 4
Santiago 4
Shenzhen 4
Tokyo 4
Vercelli 4
Warsaw 4
Berlin 3
Boston 3
London 3
Montevideo 3
Salvador 3
Tianjin 3
Tân Tiến 3
Abidjan 2
Ancona 2
Baku 2
Bangkok 2
Bogotá 2
Brescia 2
Buffalo 2
Cairo 2
Cao Lanh 2
Castel Rozzone 2
Colombo 2
Cotonou 2
Dhaka 2
Hyderabad 2
Hải Dương 2
Islamabad 2
Ixtapaluca 2
Jakarta 2
Karachi 2
Kuala Lumpur 2
La Pintana 2
Lima 2
Long Xuyen 2
Manchester 2
Medellín 2
Mexico City 2
Mumbai 2
Muscat 2
Nairobi 2
Ottawa 2
Phủ Lý 2
Querétaro 2
Quận Bình Thạnh 2
Rome 2
Sapucaia do Sul 2
Tashkent 2
Vĩnh Long 2
Ân Thi 2
Addis Ababa 1
Aden 1
Agadir 1
Aguascalientes 1
Ahmedabad 1
Algiers 1
Almaty 1
Andradina 1
Ankara 1
Totale 1.528
Nome #
Impact of CYP2C19 Genotype on Efficacy and Safety of Clopidogrel-based Antiplatelet Therapy in Stroke or Transient Ischemic Attack Patients: An Updated Systematic Review and Meta-analysis of Non-East Asian Studies 61
c-Jun N-terminal kinase 3 serum levels in ischemic stroke: Preliminary findings for a potential biomarker 45
Adapting foundation models for rapid clinical response: intracerebral hemorrhage segmentation in emergency settings 42
Renal function and Neurofilament Light Chain serum concentrations in ischemic stroke 38
Medial intracranial carotid artery calcifications and hematoma expansion in deep intracerebral hemorrhage 38
Effect of CDP-Choline on age-dependent modifications of energy and glutamate-linked enzyme activities in synaptic and non-synaptic mitochondria from rat cerebral cortex 35
c-Jun N-terminal kinase 3 (JNK3) serum levels in ischemic stroke: preliminary findings for a potential biomarker 35
Aging and cerebral ischemia during postischemic recovery: enzyme activities of Krebs’ cycle, glutamate and related amino acids as a functional proteomics approach to evaluate the responsiveness of ischemic tissue and drug actions 34
Fatty-acid Binding Protein-2 (FABP2) serum concentrations and blood lipid profile in ischemic stroke patients 34
A case report of acute thrombocytopenia induced by Apomorphine in a patient with Parkinson's disease with motor fluctuations 34
Marcatori sierici e deficit neurologico: correlazioni nei pazienti con ictus ischemico in fase acuta 34
Predictors of intracranial non-stenosing vulnerable atherosclerotic plaques in ESUS: A risk stratification model 34
Association between calcification pattern and the presence of intracranial carotid artery vulnerable non-stenosing atherosclerotic plaques in ESUS 34
Hyperglycemia in acute ischemic stroke: Physiopathological and therapeutic complexity 33
Emerging therapies for hyperglycemia in acute ischemic stroke: glucagon-like peptide 1 receptor agonists and dipeptidyl peptidase IV inhibitors 32
Relationships between serum Neurofilament Light Chain and blood inflammatory markers in acute ischemic stroke patients 32
Bioenergetic characterization of lymphocytes from stroke patients 32
Case Report: Intensive multidisciplinary motor-cognitive rehabilitation treatment in Gerstmann–Sträussler–Scheinker syndrome 32
Stress hyperglycemia indexes and early neurological deterioration in spontaneous intracerebral hemorrhage 32
Acute-phase serum biomarkers and ischemic stroke severity 32
Caratterizzazione di un pannello di biomarcatori sierici per definire l’outcome funzionale dei pazienti con ictus ischemico focalizzato sul processo infiammatorio 32
Neurofilament light chain serum concentrations and renal functions in acute ischemic stroke patients 31
Clonidine and Brain Mitochondrial Energy Metabolism: Pharmacodynamic Insights Beyond Receptorial Effects 31
Association between calcification pattern and the presence of intracranial carotid artery vulnerable non-stenosing atherosclerotic plaques in ESUS 31
Glutamate metabolism in cerebral mitochondria after ischemia and post-ischemic recovery during aging: relationships with brain energy metabolism 30
Cherishing Professional Success and Personal Fulfillment: Resilience as a Pivotal Leadership Competency for Clinical Pharmacologists and Beyond 30
Brain Bioenergetics in Chronic Hypertension: Risk Factor for Acute Ischemic Stroke 30
Relationships between serum Neurofilament Light Chain and blood inflammatory markers in acute ischemic stroke patients 30
Characterization of a panel of serum biomarkers to define functional outcome in ischemic stroke patients: focus on inflammation 30
Non-stenosing intracranial atherosclerotic lesions in embolic stroke of undetermined source: a vessel wall MRI study 30
Non-stenosing intracranial atherosclerotic lesions in embolic stroke of undetermined source: a vessel wall MRI study 30
Potential role of sequential vessel wall magnetic resonance imaging in monitoring response to antithrombotic therapy in stroke due to intracranial atherosclerotic disease: a case report. 30
Stress hyperglycemia and early neurologic deterioration in diabetic and non-diabetic patients with intracerebral hemorrhage 29
The energy metabolism of cerebral mitochondria obtained from spontaneous hypertensive rats: a proposed experimental model to study the effects of chronic hypertension and of anti-hypertensive drugs 29
ATP-ases of synaptic plasma membranes in striatum: enzymatic systems for synapses functionality by in vivo administration of L-acetylcarnitine in relation to Parkinson's disease 29
Endothelin-1 in embolic stroke of undetermined source patients with complicated non-stenosing intracranial atherosclerotic plaques 29
Potential role of sequential vessel wall magnetic resonance imaging in monitoring response to antithrombotic therapy in stroke due to intracranial atherosclerotic disease: a case report 29
Non-stenosing intracranial atherosclerotic lesions in embolic stroke of undetermined source: a vessel wall MRI study 29
Physiopathology and pharmacology of post-stroke depression: from preclinical evidence to patients’ treatment. 28
I biomarcatori sierici originati dall’unità neurovascolare nel monitoraggio del paziente con ictus ischemico: ruolo dei neurofilamenti a catena leggera. 28
Neurofilament light chain serum concentrations and renal functions in acute ischemic stroke patients. 28
Apomorphine Subcutaneous Infusion Likely Induced Acute Thrombocytopenia in a Patient with Parkinson's Disease and Motor Fluctuations 28
Non-stenosing intracranial atherosclerotic lesions in embolic stroke of undetermined source: a vessel wall MRI study. 28
Correlation of Neurofilament Light Chain serum concentrations with renal function in acute ischemic stroke patients 28
Antidepressants and cerebral energy metabolism: new functional proteomic insights. 28
Stress hyperglycemia and early neurologic deterioration in diabetic and non-diabetic patients with intracerebral hemorrhage 28
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 28
Secondary stroke prevention in intracranial atherosclerosis guided by sequential vessel wall imaging: a case series 27
Role of JNK3 signaling in acute ischemic stroke cerebroprotection: A systematic review 27
Bioenergetics of lymphocytes as potential biomarker in Alzheimer’s Disease: a functional proteomic study 27
Secondary stroke prevention in intracranial atherosclerosis guided by sequential vessel wall imaging: a case series 27
Spasmi tonici involontari di un arto da ischemia lacunare pontina: una rara manifestazione clinica d’esordio. 27
The role of the serum biomarkers NF-L and GFAP in predicting ischemic stroke patients’ outcome. 27
I neurofilamenti a catena leggera nella valutazione prognostica del paziente con ictus ischemico acuto. 26
Correlations between acute-phase serum biomarkers and the neurological deficit of ischemic patients at discharge from the Stroke Unit 26
Energy metabolism of rat cerebral cortex, hypothalamus and hypophysis during ageing 26
Valutazione delle concentrazioni sieriche di Endotelina-1 in pazienti con ictus ischemico acuto sottoposti a procedure di rivascolarizzazione. 26
Acute amnestic syndrome in fornix lesions: a systematic review of reported cases with a focus on differential diagnosis 25
Prevention of Acute and recurrent stroke by anti-hypertensives: interaction with thrombolysis. 25
Brain bioenergetics linking preclinical to clinical studies on physiopathology and treatment of affective disorders. 25
Functional proteomics of synaptic plasma membrane ATP-ases of rat hippocampus: Effect of l-acetylcarnitine and relationships with Dementia and Depression pathophysiology 25
I farmaci incretinici nella terapia dell’iperglicemia nell’ictus ischemico acuto. 25
Ruolo prognostico degli indici sistemici di infiammazione nell’emorragia intraparenchimale spontanea. 25
Endothelin-1 in embolic stroke of undetermined source patients with complicated non-stenosing intracranial atherosclerotic plaques 24
Intracranial Nonstenosing Atherosclerotic Plaques Assessed With Vessel Wall MRI in Patients With Embolic Stroke of Undetermined Source 24
Renal function and Neurofilament Light Chain serum concentrations in ischemic stroke 24
Predictors of intracranial non-stenosing vulnerable atherosclerotic plaques in ESUS: A risk stratification model 24
Energy Metabolism of Synaptosomes from Different Neuronal Systems of Rat Cerebellum During Aging: A Functional Proteomic Characterization 24
Acute-phase serum biomarkers and ischemic stroke severity 24
Warnings and drawbacks for antipsychotic and mood disorder drug prescriptions in the elderly 24
Energy metabolism of cerebral mitochondria during aging, ischemia and post-ischemic recovery assessed by functional proteomics of enzymes 24
Lymphocytes bioenergetics after stroke: a functional proteomic study 23
Bioenergetics of Desipramine: a Functional Proteomic Study 23
Synaptic ATPases and energy metabolism in the nervous system: Roles and changes during aging 23
Effect of desipramine and fluoxetine on energy metabolism of cerebral mitochondria 23
Bioenergetic effects of Clonidine on functional proteomics 23
Effects of acetylcholinesterase inhibitors on brain energy metabolism of non-synaptic and synaptic mitochondria. 22
Effects of Chronic Hypertension on the Energy Metabolism of Cerebral Cortex Mitochondria in Normotensive and in Spontaneously Hypertensive Rats During Aging 22
Bioenergetics of Fluoxetine: a functional proteomic study 22
Effetto della Somministrazione Acuta di Clonidina sul Metabolismo Energetico Cerebrale. 22
Post-stroke depression: mechanisms and pharmacological treatment 22
Functional proteomics related to energy metabolism of synaptosomes from different neuronal systems of rat hippocampus during aging 22
Mitochondrial energy metabolism of rat hippocampus after treatment with the antidepressants desipramine and fluoxetine 22
Functional proteomics of adenosine triphosphatase system in the rat striatum during aging 22
Selective effects of L-acetylcarnitine on energy-utilizing ATPases of synapses derived from hippocampal sub-fields. 22
Neuroprotection for ischaemic stroke: current status and challenges 21
The Neurobiology of Depression: an Integrated Overview from Biological Theories to Clinical Evidence 21
Glutamate metabolism in aging and experimental stroke 21
Mitochondrial Energy Metabolism of Brain and Lymphocytes after Ischemia and Recovery during Aging 21
Prevention of acute and recurrent stroke with statins and interaction with thrombolysis 21
Functional proteomics as marker for neurological and psychiatric disorders: the first application to dementia for an immediate future 21
Effect of in vivo L-acetylcarnitine administration on ATP-ases enzyme systems of synaptic plasma membranes from rat cerebral cortex 21
Il ruolo della concentrazione sierica dei Neurofilamenti a Catena Leggera (Nf-L) e della Proteina Fibrillare Acida della Glia (GFAP) nella valutazione prognostica del paziente con Ictus Ischemico. 20
Use of cangrelor in cervical and intracranial stenting for the treatment of acute ischemic stroke: A real life single-center experience 20
Effect of in vivo administration of L-acetylcarnitine on ATP-ases of synaptic plasma membranes of rat striatum 20
The treament of hyperglycemia in acute ischemic stroke with incretin-based drugs 20
Functional proteomics of energy-linked enzymes in lymphocytes after stroke 19
Intracranial carotid artery calcification morphology differs in patients with lacunar and nonlacunar acute ischemic strokes 19
Bioenergetics of lymphocytes as biomarkers of ischemic stroke patients during aging 19
Quantification and prospective evaluation of serum NfL and GFAP as blood-derived biomarkers of outcome in acute ischemic stroke patients 19
Totale 2.738
Categoria #
all - tutte 5.834
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.834


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20246 0 0 0 0 0 0 0 1 4 0 0 1
2024/202514 0 0 2 0 0 2 2 1 3 1 1 2
2025/20263.182 0 2 5 3 309 105 815 883 334 726 0 0
Totale 3.202